Nurix Appoints Robert Tjian, Ph.D. Of The Column Group To Its Board Of Directors

SAN FRANCISCO--(BUSINESS WIRE)--Nurix, Inc., a private drug discovery company, today announced the appointment of Dr. Robert Tjian to the company’s board of directors.

Dr. Tjian is a member of the National Academy of Sciences and has received numerous awards including the Alfred P. Sloan Prize and the Louisa Gross Horwitz Prize. He was a co-founder of Tularik with Dave Goeddel and Steve McKnight and most recently served as president of the Howard Hughes Medical Institute (HHMI) from 2009 to 2016. After leaving HHMI, Dr. Tjian joined The Column Group as a discovery partner in September 2016.

Back to news